Population Pharmacokinetic Modeling of Olaratumab, an Anti-PDGFRα Human Monoclonal Antibody, in Patients with Advanced and/or Metastatic Cancer.
Pharmacokinetic modelling of populations of Olaratumab, an anti-PDGFR human monoclonal antibody in patients with advanced and/or metastatic cancer